Invokana Preventative Measures

Before taking Invokana, or if you are currently taking Invokana, make sure to tell your doctor if any of the following issues apply to you, as they increase your likelihood of having medical problems by taking Invokana: kidney disease, heart disease, abnormal blood pressure, high cholesterol, liver disease, an electrolyte imbalance (such as high levels of potassium in your blood), if you plan to become pregnant, are pregnant, or are breastfeeding. If you have other concerns, it is always a good idea to talk to your physician or other healthcare provider.

Canagliflozin Manufacturer's logo.
Canagliflozin Manufacturer's logo.




 

Invokana Precautions

If you are currently taking Invokana watch for any signs of kidney failure, heart problems and ketoacidosis. If you experience symptoms such as chest pain, dizziness, faintness, increased heart rate, increased pulmonary rate, difficulty breathing, hyperventilation, weakness, changes in urination, anorexia, nausea, vomiting, abdominal pain, or confusion, seek immediate medical help. Do not stop or change your diabetes medication without instructions from your physician.

 

Has There Been A Recall?

No, Invokana has not been recalled. However, the manufacturer, Janssen, is currently examining many severe side effects and a recall may be necessary if studies find evidence of deadly risks. According to the New York Times when the FDA approved Invokana they indicated that: “the label of the drug includes no warnings about heart attacks or strokes. … The FDA is requiring Johnson & Johnson to conduct five post-marketing studies, including a clinical trial to determine more definitively if the drug increases those risks.”

 

We Can Help!

If you or a loved one was diagnosed with ketoacidosis or kidney failure after taking Invokana, please contact Jensen & Associates immediately for a free case evaluation. You may use the form to the right, email us at MyCase@InvokanaAdvice.com or call us toll-free at 1-800-803-3784. We can help.

 

Free Case Evaluation